Diversigen, a portfolio company of Baylor College of Medicine, has been sold to OraSure Technologies

Client: Baylor College of Medicine

Client Location: United States

Target: Diversigen, Inc.

Target Location: United States

Buyer: OraSure Technologies (NASDAQ:OSUR)

Buyer Location: United States

Target Description: Diversigen is a leading provider of comprehensive, integrated and multidimensional insights into the diverse microbiomes of living organisms and environments.

Diversigen Baylor College Of Medicine Orasure Technologies 2019
  • 2019
    Close Year
  • Healthcare
  • Private
    Client Type
  • Strategic | Domestic
    Transaction Type
  • USA

Meet our Senior Team